We did propensity score–matching analysis for carperitide use in acute heart failure.
Carperitide use was associated with >2-fold higher in-hospital mortality.
In all subgroups except nonelderly (<75 y) the results were consistent.
Our results suggest the necessity of randomized clinical trials of carperitide.